A narrative review of peripheral blood parameters for urothelial carcinoma treated with systemic
antitumor drugs - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Objective The study investigates the diagnostic and prognostic value of the aspartate
aminotransferase (AST) to alanine aminotransferase (ALT) ratio in patients with sepsis and …

The aim of this study is to evaluate the factors affecting the objective response rate (ORR)
after neoadjuvant therapy of taxol plus platinum (TP) regimen combined with programmed …

Glutamine, the most abundant non-essential amino acid in human blood, is crucial for
cancer cell growth and cancer progression. Glutamine mainly functions as a carbon and …

Simple Summary This article describes the results of a study that checked the association
between low levels of ALT (an enzyme) in the blood and the outcomes of patients suffering …

Background: A high pre-treatment De Ritis ratio, the aspartate transaminase/alanine
aminotransferase ratio, has been suggested to be of prognostic value for mortality in muscle …

This study aimed to investigate whether changes in the De Ritis ratio (DRR) can be used to
stratify the mortality risk of patients with moderate-to-severe traumatic brain injury (TBI). This …

Background and purpose Immunotherapy, with or without radiotherapy (iRT or ICIs-nonRT),
is the standard treatment for non–small cell lung cancer (NSCLC). Nonetheless, the …

Introduction The De Ritis ratio, which is the ratio of aspartate aminotransferase (AST) to
alanine aminotransferase (ALT), has been suggested as a potential prognostic marker for …

The De Ritis ratio is widely used to differentiate various causes of liver disease and serves
as an independent prognostic predictor for different malignancies and non-malignant …